Well-known examples of mutated oncogenic members are found in the epidermal growth factor receptor/Erb-B2 receptor tyrosine kinases (EGFR/ERBB) family involved in lung adenocarcinoma and other non-small cell lung carcinomas, breast cancer, and colorectal and gastric cancer. This evidence concerns the gene EGFR and breast cancer.